Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ADMA Biologics Inc (NASDAQ:ADMA)

3.56
Delayed Data
As of Jul 21
 -0.05 / -1.39%
Today’s Change
2.93
Today|||52-Week Range
8.00
-30.47%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
AssetsCash26.1M17.2M10.4M9.9M
 
 
 
 
 
Short Term Investment Cash13.6M-9.0M-6.8M-526.1K
 
 
 
 
 
Cash & Short Term Investments29.1M21.9M16.8M15.3M
 
 
 
 
 
 
ReceivablesReceivables0.00384.0K924.5K1.0M
 
 
 
 
 
InventoriesInventories1.7M1.7M3.4M5.0M
 
 
 
 
 
 
Current AssetsPrepaid Expenses298.7K143.6K111.0K313.9K
 
 
 
 
 
Current Assets31.1M24.1M21.3M21.7M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross1.8M4.1M4.2M4.2M
 
 
 
 
 
Depreciation-1.0M-1.3M-1.8M-2.2M
 
 
 
 
 
Other Assets162.2K298.8K27.2K27.2K
 
 
 
 
 
Total Assets32.0M27.2M23.7M23.7M
 
 
 
 
 
 
LiabilitiesAccounts Payable2.7M1.8M2.1M2.6M
 
 
 
 
 
Short Term Debt12.7K13.8K15.1K6.1M
 
 
 
 
 
Accrued Expenses860.1K2.3M2.0M2.4M
 
 
 
 
 
Other Current Liabilities935.7K2.4M2.1M2.5M
 
 
 
 
 
Other Liabilities3.7M4.2M4.2M11.2M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt5.1M15.0M15.7M14.1M
 
 
 
 
 
Other Liabilities0.00476.8K128.7K98.1K
 
 
 
 
Total Liabilities10.4M21.2M22.9M28.1M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity21.6M6.0M821.0K-4.5M
 
 
 
 
 
Total Shareholder Equity21.6M6.0M821.0K-4.5M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding9.3M9.3M10.7M12.9M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.